Naorungroj, Thummaporn
Neto, Ary Serpa
Wang, Amanda
Gallagher, Martin
Bellomo, Rinaldo
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial
https://doi.org/10.1371/journal.pmed.1001601
Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials
https://doi.org/10.1186/s13054-022-04151-5
Documents that mention this clinical trial
Cochrane Renal Group Report
https://doi.org/10.1053/j.ajkd.2005.07.035
Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials
https://doi.org/10.1186/s13054-022-04151-5
Article History
Received: 6 July 2022
Accepted: 30 August 2022
First Online: 6 September 2022
Declarations
:
: The RENAL trial was approved by the human research ethics committees of the University of Sydney and all participating institutions. The ATN study was approved by the Human Rights Committee at the West Haven VA Cooperative Studies Program (CSP) Coordinating Center and by the institutional review boards at each of the participating study sites. Written informed consent was obtained from the patient or responsible surrogate, and the research was carried out following the Declaration of Helsinki.
: Written informed consent was obtained from all patients or their responsible surrogates in both RENAL and ATN study.
: Dr Serpa Neto reported receiving grants and personal fees from Dräger, outside the submitted work. Dr Bellomo reported receiving grants from Baxter International outside the submitted work. Dr Naorungroj declared that they have no relevant financial interests. Dr Amanda Y Wang is supported by RACP Jacquot Research Establishment Fellowship, Australia.